Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial

scientific article published on 25 October 2012

Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/JAHA.112.003640
P932PMC publication ID3541632
P698PubMed publication ID23316301
P5875ResearchGate publication ID234125153

P50authorJeremiah StamlerQ6180986
Lewis KullerQ88077314
Judith K. OckeneQ113389547
P2093author name stringJames D Neaton
Jerome D Cohen
Ronald Prineas
MRFIT Research Group
Gregory Grandits
Jeffrey Cutler
Lynn Eberly
P2860cites workUse of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studiesQ24658205
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studiesQ28036762
Composite outcomes in randomized trials: greater precision but with greater uncertainty?Q35132213
Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the Multiple Risk Factor Intervention TrialQ45098556
Risk factors for death from different types of stroke. Multiple Risk Factor Intervention Trial Research Group.Q46140663
The multiple risk intervention trial (MRFIT). IV. Intervention on blood lipidsQ49122058
The multiple risk factor intervention trial (MRFIT). III. The model for interventionQ49122085
Multiple-stage screening and mortality in the Multiple Risk Factor Intervention TrialQ58489800
Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT). The Multiple Risk Factor Intervention Trial GroupQ67577118
Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research GroupQ68497359
Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention TrialQ68579824
Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research GroupQ69884095
The multiple risk factor intervention trial (MRFIT) II. The development of the protocolQ70184566
The multiple risk factor intervention trial (MRFIT). V. Intervention on smokingQ70184570
Multiple risk factor intervention trial (MRFIT)Q70184573
Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research GroupQ70255536
Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention TrialQ71493549
The Multiple Risk Factor Intervention Trial (MRFIT). A return to a landmark trialQ73071036
P433issue5
P921main subjectrisk factorQ1475848
P304page(s)e003640
P577publication date2012-10-25
P1433published inJournal of the American Heart Association: Cardiovascular and Cerebrovascular DiseaseQ19880670
P1476titleMultiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial
P478volume1

Reverse relations

cites work (P2860)
Q37334002Achieving the composite endpoint of glycated haemoglobin <7.0%, no weight gain and no hypoglycaemia in the once-weekly dulaglutide AWARD programme
Q55344919Age- and sex-related difference of lipid profile in patients with ischemic stroke in China.
Q92840040Association of RBM5 rs2013208 SNP with serum lipid levels in two Chinese ethnic groups
Q64068072Associations of Genetic Variations in and Lifestyle Factors with Coronary Artery Disease in a Southern Chinese Population with Dyslipidemia: A Nested Case-Control Study
Q40354433Cardiovascular Health and Healthcare Utilization and Expenditures Among Medicare Beneficiaries: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study
Q34029171Sex-specific association of the peptidase D gene rs731839 polymorphism and serum lipid levels in the Mulao and Han populations
Q52315936The effects of interventions targeting multiple health behaviors on smoking cessation outcomes: a rapid realist review protocol.
Q40657902What is the association of lipid levels and incident stroke?

Search more.